The US Food and Drug Administration has been lining up contractors to help it with a variety of drug quality-related initiatives, most notably an ambitious effort to assess the quality management maturity of individual pharmaceutical manufacturing facilities.
The agency already has enlisted the help of St. Gallen University and Dun & Bradstreet for a survey-based study, while...





